[Agrawal DK, Mishra PK. (2010). Curcumin and its analogues: potential anticancer agents. Med Res Rev 30: 818-860.]Search in Google Scholar
[Ashrafi SA, Hosseinimehr SJ, Varmira K, Abedi SM. (2012). Radioimmunotherapy with (131)I-bevacizumab as a specifi c molecule for cells with overexpression of the vascular endothelial growth factor. Cancer Biother Radiopharm 27: 420-425.]Search in Google Scholar
[Baugnet-Mahieu L, Lemaire M, Leonard ED, Leonard A, Gerber GB. (1994). Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 140: 429-431.]Search in Google Scholar
[Bushnell Dl, Boles MA, Kaufman GE, Wadas MA, Barnes WE. (1992). Complications, sequela and dosimetry of Iodine-131 therapy for thyroid carcinoma. J Nucl Med 33: 2214-2221.]Search in Google Scholar
[Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MA. (2004). Curcumin confers radiosensitizing eff ect in prostate cancer cell line Pc-3. Oncogene 23(8): 1599-607.]Search in Google Scholar
[Cho YJ, Yi CO, Jeon BT, Jeong YY, Kang GM, Lee JE et al. (2013). Curcumin attenuates radiation-induced infl ammation and fi brosis in rat lungs. Korean J Physiol Pharmacol 17: 267-274.]Search in Google Scholar
[Goel A, Aggarwal BB. (2010). Curcumin, the golden spice from indian saff ron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62: 919-930.]Search in Google Scholar
[Hosseinimehr SJ, Shafaghati N, Hedayati M. (2013). Genotoxicity induced by iodine-131 in human cultured lymphocytes. Interdiscip Toxicol 6: 74-76.]Search in Google Scholar
[Kalpana C, Menon VP. (2004). Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 53: 82-86.]Search in Google Scholar
[Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB et al. (2008). Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappab- regulated gene products. Clin Cancer Res 14: 2128-2136.]Search in Google Scholar
[Kuttan R, Bhanumathy P, Nirmala K, George MC. (1985). Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29: 197-202.]Search in Google Scholar
[Little JB. (2000). Radiation Carcinogenesis. Carcinogenesis 21: 397-404.]Search in Google Scholar
[Lopez-Jornet P, Camacho-Alonso F, Gomez-Garcia F. (2011). Eff ect of curcumin and irradiation in Pe/Ca-Pj15 oral squamous cell carcinoma. Acta Odontol Scand 69: 269-273.]Search in Google Scholar
[Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. (1999). Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem 47: 4297-4300.]Search in Google Scholar
[Noaparast Z, Hosseinimehr SJ. (2013). Radioprotective agents for the prevention of side eff ects induced by radioiodine-131 therapy. Future Oncology 9: 1145-1159.]Search in Google Scholar
[Polasa K, Naidu AN, Ravindranath I, Krishnaswamy K. (2004). Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat Res-Gen Tox En 557: 203-213.]Search in Google Scholar
[Robbins RJ, Schlumberger MJ. (2005). the evolving role of 131I for the treatment of diff erentiated thyroid carcinoma. J Nucl Med 46: 28S-37S.]Search in Google Scholar
[Sawin Ct, Becker DV. (1997). Radioiodine and the treatment of hyperthyroidism: The early history. Thyroid 7: 163-176.]Search in Google Scholar
[Shafaghati N, Hedayati N, Hosseinimehr SJ. (2014). Protective eff ects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells. Pharmacognosy Magazine: 10: 106-110.]Search in Google Scholar
[Singh G, Sharma S, Choudhary N, Yadav S, Chauhan R, Dwivedi J. (2012). evaluation of radioprotective properties of curcuma longa rhizome extract: a cytogenetic analysis in cancer. Pharmacognosy Communications 2: 44-49.]Search in Google Scholar
[Srinivasan M, Rajendra Prasad N, Menon VP. (2006). Protective eff ect of curcumin on gamma-radiation induced dna damage and lipid peroxidation in cultured human lymphocytes. Mutat Res 611: 96-103.]Search in Google Scholar
[Watanabe N, Kanegane H, Kinuya S, Shuke N, Yokoyama K, Kato H et al. (2004). The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of b lymphocytes. J Nucl Med 45: 608-611.]Search in Google Scholar
[Zanzonico PB. (1997). radiation dose to patients and relatives incident to 131I therapy. Thyroid 7: 199-204 10.1089/thy.1997.7.1999133684]Search in Google Scholar
